pipeline | autoimmune/inflammation | oncology
We expect to file our first IND for autoimmune/inflammatory disease in Q4-2018. Our first IND for oncology in planned for 2019.
We managed to briefly pry some of the Alpine team away from their work on cancer immunotherapy (and autoimmune dise… twitter.com/i/web/status/10076…
June 15, 2018 5:24 pm
We have a number of open positions, including 5 new ones posted today:
VP/Head Clinical Development
ED/VP/Head Tran… twitter.com/i/web/status/10051…
June 8, 2018 9:05 pm
© 2018 Alpine Immune Sciences. All Rights Reserved, Alpine Immune Sciences Inc.